Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study
| Image |  |
|---|---|
| Description | scientific article published on 27 February 2018 |
| Author/s |
author: Andreas Schneeweiss Matthias W. Beckmann Peter A. Fasching |
| Publication date | February 27, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |